UBS Group »

Sage Therapeutics shares owned by UBS Group

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.4M 203k 21.67
2023-09-30 $2.1M 103k 20.58
2023-06-30 $3.8M 80k 47.02
2023-03-31 $3.4M 80k 41.96
2022-12-31 $3.9M 102k 38.14
2022-09-30 $800k 21k 39.09
2022-06-30 $2.4M 75k 32.33
2022-03-31 $4.4M 133k 33.04
2021-12-31 $5.7M 134k 42.60
2021-09-30 $4.3M 98k 44.27
2021-06-30 $1.5M 27k 56.77
2021-03-31 $2.4M 32k 74.83
2020-12-31 $997k 12k 86.86
2020-09-30 $1.3M 22k 61.11
2020-06-30 $2.5M 61k 41.59
2020-03-31 $420k 15k 28.75
2019-12-31 $819k 11k 72.92
2019-09-30 $2.4M 17k 140.29
2019-06-30 $5.0M 27k 183.11
2019-03-31 $4.9M 31k 157.61
2018-12-31 $4.5M 47k 95.84
2018-09-30 $2.8M 20k 141.28
2018-06-30 $3.3M 21k 156.56
2018-03-31 $3.8M 24k 161.13
2017-12-31 $1.1M 6.9k 164.65
2017-09-30 $3.7M 60k 62.30
2017-06-30 $950k 12k 79.62
2017-03-31 $1.5M 21k 71.09
2016-12-31 $1.7M 33k 51.05
2016-09-30 $8.1M 175k 46.05
2016-06-30 $522k 17k 30.41
2016-03-31 $55k 1.8k 30.53
2015-12-31 $1.8M 30k 58.30
2015-09-30 $13k 300 43.33
2015-03-31 $15k 300 50.00